Here are some of the things being said about rimonabant by doctors. Keep in mind that some of these may have an interest in the clinical trials underway sponsored by Sanofi-Synthelabo Inc.

"It will be very widely prescribed if found safe and effective in the remaining trials that are due to come out over the next year or two."

Dr.Christopher Cannon, a cardiologist at Brigham and Women's Hospital in Boston and an associate professor of medicine at Harvard University, quoted on Aug. 29. 2004 by Bloomberg.

"Rimonabant shows a substantial weight reduction, and if that's possible without side effects it could be promising. I have concerns about the idea you just buy a drug and that's it, buying weight reduction instead of changing lifestyle habits.''

Dr.Otto Smiseth, a professor of medicine at University of Oslo, quoted on Aug. 29. 2004 by Bloomberg.

---

"We come up with new drugs on the drawing board all the time, but rarely do they work the way we think they will. This one did. I think the drug has incredible potential."

Dr. Elbert Glover of West Virginia University Medical School quoted in the Aug. 14, 2004 issue of Newsweek.